Related Experiment Video
Updated: Mar 8, 2026
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
New discoveries in the molecular landscape of bladder cancer
Roger Li1, Woonyoung Choi1, J E Ferguson Rd1
1Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
We are currently on the cusp of exponential growth in the understanding of the molecular landscape of bladder cancer. Emerging data regarding the mutational burden and targetable genomic and protein alterations in bladder cancer have allowed us to tap into treatments directed toward specific molecular characteristics of bladder cancer. In parallel, these developments will enable us to better select patients for existing treatments of bladder cancer in a step toward personalized therapy. The present article reviews select discoveries that have advanced our understanding of bladder cancer and gives a glimpse of the exciting opportunities on the not-so-distant horizon.
Insights
Bladder cancer research is rapidly advancing, revealing molecular targets for personalized treatments. Understanding these molecular characteristics will improve patient selection for existing therapies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Bladder cancer research is experiencing significant growth in understanding its molecular underpinnings.
- Genomic and protein alterations are increasingly identified as potential therapeutic targets.
Purpose of the Study:
- To review recent discoveries in bladder cancer molecular landscape.
- To highlight future opportunities for targeted and personalized therapies.
Main Methods:
- Review of emerging data on mutational burden.
- Analysis of targetable genomic and protein alterations.
- Exploration of advancements in patient selection for bladder cancer treatments.
Main Results:
- Emerging data reveals a complex molecular landscape in bladder cancer.
- Identification of specific molecular targets enables development of directed treatments.
- Improved patient selection for existing therapies is becoming feasible.
Conclusions:
- The molecular understanding of bladder cancer is rapidly expanding.
- Targeted therapies based on molecular characteristics are on the horizon.
- Personalized medicine approaches will improve bladder cancer treatment outcomes.
